BR9913154A - Composição de musse - Google Patents

Composição de musse

Info

Publication number
BR9913154A
BR9913154A BR9913154-4A BR9913154A BR9913154A BR 9913154 A BR9913154 A BR 9913154A BR 9913154 A BR9913154 A BR 9913154A BR 9913154 A BR9913154 A BR 9913154A
Authority
BR
Brazil
Prior art keywords
composition
occlusive
active ingredient
occlusive agent
pharmaceutically active
Prior art date
Application number
BR9913154-4A
Other languages
English (en)
Portuguese (pt)
Inventor
Albert Zorko Abram
Original Assignee
Soltec Res Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3810055&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9913154(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Soltec Res Pty Ltd filed Critical Soltec Res Pty Ltd
Publication of BR9913154A publication Critical patent/BR9913154A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Cosmetics (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
BR9913154-4A 1998-09-11 1999-09-08 Composição de musse BR9913154A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP5831A AUPP583198A0 (en) 1998-09-11 1998-09-11 Mousse composition
PCT/AU1999/000735 WO2000015193A1 (en) 1998-09-11 1999-09-08 Mousse composition

Publications (1)

Publication Number Publication Date
BR9913154A true BR9913154A (pt) 2001-05-15

Family

ID=3810055

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9913154-4A BR9913154A (pt) 1998-09-11 1999-09-08 Composição de musse

Country Status (13)

Country Link
US (3) US6730288B1 (https=)
EP (2) EP1112062B1 (https=)
JP (1) JP4603164B2 (https=)
AT (1) ATE381315T1 (https=)
AU (2) AUPP583198A0 (https=)
BR (1) BR9913154A (https=)
CA (1) CA2333869C (https=)
DE (1) DE69937802T2 (https=)
DK (1) DK1112062T3 (https=)
ES (2) ES2299258T3 (https=)
NZ (1) NZ508259A (https=)
PT (1) PT1112062E (https=)
WO (1) WO2000015193A1 (https=)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9504265D0 (en) 1995-03-03 1995-04-19 Medeva Plc Corticosteroid-containing pharmaceutical composition
AUPO983897A0 (en) 1997-10-17 1997-11-06 Soltec Research Pty Ltd Topical antifungal composition
AUPP310798A0 (en) 1998-04-22 1998-05-14 Soltec Research Pty Ltd Vehicle system for a composition comprising a piperidinopyrimidine derivative
FR2761600B1 (fr) 1998-06-19 2000-03-31 Oreal Composition moussante pour le lavage et le traitement des cheveux et/ou du cuir chevelu a base d'un principe actif, d'un tensioactif anionique, d'un tensioactif amphotere et d'un agent propenetrant
AUPP583198A0 (en) * 1998-09-11 1998-10-01 Soltec Research Pty Ltd Mousse composition
US8263580B2 (en) 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
JP2003012501A (ja) * 2001-06-27 2003-01-15 Rohto Pharmaceut Co Ltd 鎮痒エアゾール製剤
US20050129722A1 (en) * 2002-03-13 2005-06-16 Collagenex Pharmaceuticals, Inc. Water-based delivery systems
AU2003233396B2 (en) * 2002-03-13 2007-05-24 Thomas Skold Water-based delivery systems
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US20060233721A1 (en) * 2002-10-25 2006-10-19 Foamix Ltd. Foam containing unique oil globules
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20080031907A1 (en) * 2002-10-25 2008-02-07 Foamix Ltd. Cosmetic and pharmaceutical foam
ES2532906T5 (es) 2002-10-25 2022-03-23 Foamix Pharmaceuticals Ltd Espuma cosmética y farmacéutica
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US9668972B2 (en) * 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US7700076B2 (en) * 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US8119150B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US20050271596A1 (en) * 2002-10-25 2005-12-08 Foamix Ltd. Vasoactive kit and composition and uses thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
EA014372B1 (ru) 2003-01-24 2010-10-29 Стифел Рисерч Оустрэйлиа Пти Лтд. Пена на основе фосфата клиндамицина
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
WO2004100918A1 (ja) * 2003-05-13 2004-11-25 The Nisshin Oillio, Group, Ltd. 水中油型乳化化粧料
US7186416B2 (en) 2003-05-28 2007-03-06 Stiefel Laboratories, Inc. Foamable pharmaceutical compositions and methods for treating a disorder
JP4615198B2 (ja) * 2003-07-25 2011-01-19 久光製薬株式会社 抗真菌エアゾール外用製剤
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
EP1663148A2 (en) * 2003-08-25 2006-06-07 Foamix Ltd. Penetrating pharmaceutical foam
WO2005055921A2 (en) 2003-12-12 2005-06-23 Eran Eilat Compositions for treatment of ear disorders and methods of use thereof
US8940321B2 (en) 2003-12-12 2015-01-27 Otic Pharma Ltd. Compositions for treatment of ear disorders and methods of use thereof
EP1727522A2 (en) * 2004-02-04 2006-12-06 Foamix Ltd. Cosmetic and pharmaceutical foam with solid matter
WO2005099713A2 (es) * 2004-04-05 2005-10-27 Laboratorios Liomont, S.A. De C.V. Nueva presentación de una composición farmacéutica antiviral
AU2006298442A1 (en) * 2005-05-09 2007-04-12 Foamix Ltd. Saccharide foamable compositions
DK1879595T3 (en) * 2005-05-10 2015-01-05 Dermipsor Ltd Preparations and Methods for the Treatment of Hyperproliferative Epidermal Diseases
US20060264344A1 (en) * 2005-05-23 2006-11-23 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Mild foaming cleansing composition
WO2006129161A2 (en) 2005-06-01 2006-12-07 Stiefel Research Australia Pty Ltd Vitamin formulation
CN101340884A (zh) 2005-10-19 2009-01-07 曼尼·马纳舍·辛格尔 用于治疗多汗症的方法
ES2560540T3 (es) 2006-03-31 2016-02-19 Stiefel Research Australia Pty Ltd Gel en suspensión espumable
US9023863B2 (en) * 2006-07-14 2015-05-05 Stiefel Research Australia Pty Ltd Fatty acid pharmaceutical foam
EP2073794A2 (en) * 2006-11-14 2009-07-01 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
US20080260655A1 (en) * 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
TW200904485A (en) * 2007-05-18 2009-02-01 Alcon Res Ltd Phospholipid compositions for contact lens care and preservation of pharmaceutical compositions
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
CA2712120A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
TW201010727A (en) * 2008-09-03 2010-03-16 Alcon Res Ltd Pharmaceutical composition having relatively low ionic strength
CN102438590B (zh) 2009-02-25 2013-07-10 施泰福研究澳大利亚有限公司 局部泡沫组合物
FR2943914A1 (fr) * 2009-04-06 2010-10-08 Fabre Pierre Dermo Cosmetique Flacon mousseur comprenant une composition pharmaceutique
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US10029013B2 (en) 2009-10-02 2018-07-24 Foamix Pharmaceuticals Ltd. Surfactant-free, water-free formable composition and breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
ES2537151T3 (es) 2009-12-10 2015-06-02 Neubourg Skin Care Gmbh & Co. Kg Formulaciones de espuma estabilizadas con polímeros, libres de emulsionantes
JP5927506B2 (ja) 2010-04-13 2016-06-01 レルマダ セラピューティクス、インク． １−メチル−２’，６’−ピペコロキシリダイドの皮膚医薬組成物および使用方法
AU2011264198B2 (en) 2010-06-11 2015-04-09 Leo Pharma A/S A pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid
CA2842277C (en) 2011-07-20 2020-11-03 Perrigo Israel Pharmaceuticals Ltd Topical oily foam compositions
US8911754B2 (en) 2011-10-11 2014-12-16 Fallien Cosmeceuticals, Ltd. Foamable sunscreen formulation
WO2013065051A1 (en) 2011-11-01 2013-05-10 Naveh Pharma (1996) Ltd. Formulation and device for treating ceruminosis
CA2896429A1 (en) 2012-12-26 2014-07-03 Otic Pharma Ltd. Foamable otic pharmaceutical compositions
CA2936416C (en) * 2014-02-14 2022-05-31 Mission Pharmacal Company Stabilized, sprayable emulsion containing active agent particles
EP3104842B1 (en) 2014-02-14 2021-10-06 Mission Pharmacal Company Sprayable composition containing zinc oxide and a fluoro-olefin propellant
MX380855B (es) 2014-02-14 2025-03-12 Mission Pharma Co Dispositivo para suministro de rocío.
AU2015238224B2 (en) 2014-03-28 2020-05-14 Galderma Research & Development Non-rinse chemical mousse containing benzoyl peroxide
US9265727B1 (en) 2015-01-14 2016-02-23 Delcor Asset Corporation Spray foam corticosteroid product
CN107405305B (zh) 2015-01-20 2020-12-25 泰特拉德姆集团有限责任公司 提供粘膜和皮肤屏障恢复的通用局部药物递送载体和多因子组织保湿剂
US10716740B2 (en) 2015-03-24 2020-07-21 The Procter & Gamble Company Foam compositions, aerosol products, and methods of using the same to improve sensory benefits to the skin
FR3041541B1 (fr) 2015-09-29 2018-11-30 Galderma Research & Development Mousse chimique non rincee comprenant de l'ivermectine
FR3041538B1 (fr) * 2015-09-29 2018-11-30 Galderma Research & Development Mousse chimique non rincee contenant du propionate de clobetasol, et son utilisation dans le traitement du psoriasis.
FR3041535B1 (fr) 2015-09-29 2019-01-25 Galderma Research & Development Mousse chimique non rincee contenant du trifarotene, et son utilisation dans le traitement de l'ichtyose.
FR3041536B1 (fr) 2015-09-29 2018-11-30 Galderma Research & Development Mousse chimique non rincee contenant du trifarotene, et son utilisation dans le traitement de l'acne.
FR3041539B1 (fr) 2015-09-29 2018-10-26 Galderma Research & Development Composition nettoyante auto-moussante contenant du propionate de clobetasol, et son utilisation dans le traitement du psoriasis.
FR3041537B1 (fr) 2015-09-29 2018-11-30 Galderma Research & Development Mousse chimique non rincee contenant de la brimonidine et son utilisation dans le traitement de la rosacee.
MX377365B (es) 2016-09-08 2025-03-10 Journey Medical Corp Composiciones y métodos para tratar rosácea y acné.
US12097186B2 (en) 2019-04-30 2024-09-24 Bayer Healthcare Llc Topical analgesic compositions
CA3138194A1 (en) 2019-04-30 2020-11-05 Bayer Healthcare Llc Topical analgesic gel compositions

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3330730A (en) * 1962-08-03 1967-07-11 Colgate Palmolive Co Pressurized emulsion quick breaking foam compositions
US3829563A (en) * 1972-11-30 1974-08-13 Hoffmann La Roche Emollient cleansing compositions
LU71012A1 (https=) * 1974-09-26 1976-08-19
FR2350095A1 (fr) * 1976-05-03 1977-12-02 Oreal Compositions destinees a la coloration de la peau a base de derives de la pyridine
US4185100A (en) * 1976-05-13 1980-01-22 Johnson & Johnson Topical anti-inflammatory drug therapy
US4317817A (en) * 1979-08-27 1982-03-02 Richardson-Merrell Inc. Novel steroid 5α-reductase inhibitors
US4267173A (en) * 1979-11-05 1981-05-12 Schering Corporation Use of 6β-fluoro-7α-halogenocorticoids as topical anti-inflammatories and pharmaceutical formulations useful therefor
US4305936A (en) * 1980-10-09 1981-12-15 Dermik Laboratories Topical corticosteroid formulations
US4631064A (en) * 1982-06-01 1986-12-23 The Proctor & Gamble Company Depilatory compositions
US4618344A (en) * 1982-06-01 1986-10-21 The Procter & Gamble Company Depilatory compositions
GB8315787D0 (en) * 1983-06-08 1983-07-13 Briggs J H Coolant spray
US4607028A (en) * 1983-08-18 1986-08-19 Ciba-Geigy Corporation Novel carboxylic acid esters
CA1272953A (en) * 1984-10-08 1990-08-21 Yuji Makino Pharmaceutical composition for external use containing active-type vitamin d.sub.3
DE3670569D1 (de) * 1985-03-01 1990-05-31 Procter & Gamble Milder reinigungsschaum.
US4847068A (en) * 1987-08-06 1989-07-11 Johnson & Johnson Consumer Products, Inc. Skin care compositions
US4981677A (en) * 1987-09-23 1991-01-01 L'oreal Petrolatum-containing aerosol foam concentrate
CA1308664C (fr) * 1987-09-23 1992-10-13 Paul Thau Composition de traitement de la peau sous forme de mousse aerosol contenant de la vaseline (marque de commerce)
US5143717A (en) * 1987-12-30 1992-09-01 Code Blue Medical Corporation Burn foam and delivery system
US4992478A (en) * 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
EP0484530B1 (en) * 1989-07-28 1995-07-12 Hisamitsu Pharmaceutical Co., Inc. Foamed aerosol preparation
US5037655A (en) * 1990-04-18 1991-08-06 Giovanoni Richard L Method of stabilizing tretinoin
US5167950A (en) * 1991-03-28 1992-12-01 S. C. Johnson & Son High alcohol content aerosol antimicrobial mousse
US5252331A (en) * 1992-03-05 1993-10-12 Lorenzo Freeman Less irritating shaving material
WO1994013257A1 (en) * 1992-12-16 1994-06-23 Creative Products Resource Associates, Ltd. Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder
US5420106A (en) * 1994-03-22 1995-05-30 Bristol-Myers Squibb Company Method and composition having enhanced alpha-hydroxy acid skin permeation and retention
DE69513389T2 (de) * 1994-03-24 2000-06-29 Ciba Specialty Chemicals Holding Inc., Basel Dl-di od. tri hydroxyphenylglycinalkylester zur behandlung entzündlicher und allergischer zustände
US5976555A (en) * 1994-09-07 1999-11-02 Johnson & Johnson Consumer Products, Inc. Topical oil-in-water emulsions containing retinoids
GB9504265D0 (en) * 1995-03-03 1995-04-19 Medeva Plc Corticosteroid-containing pharmaceutical composition
EP0738510A3 (fr) 1995-04-20 2005-12-21 L'oreal Utilisation d'un inhibiteur d'HMG-coenzyme A-reductase pour lutter contre le vieillissement de la peau et pour traiter l'acné. Composition comprenant au moins un inhibiteur HMG-coenzyme A reductase et au moins un actif possédant des propriétes desquamantes
US5902805A (en) * 1996-04-22 1999-05-11 L'oreal Method for treatment of acne and/or the effects of ageing using HMG-coenzyme A-reductase inhibitor and compositions for performing the same
DE19631221C2 (de) * 1996-08-02 1999-07-01 Beiersdorf Ag Schaumförmige Lichtschutzzubereitungen mit einem Gehalt an wasserlöslichen Lichtschutzfiltersubstanzen und grenzflächenaktiven Substanzen
US6008254A (en) * 1997-05-09 1999-12-28 Kligman; Douglas E. Method of treating skin disorders with high-strength tretinoin
GB2327344A (en) 1997-07-18 1999-01-27 Ninh Thuy On Pharmaceutical compositions containing phenytoin and either an azole anti-fungal/anti-bacterial agent and/or a silver salt for topical application
US5965500A (en) 1997-07-24 1999-10-12 Levers Brothers Company, Division Of Conopco, Inc. Stable liquid composition comprising high levels of emollients
DE59802564D1 (de) * 1997-08-18 2002-01-31 Neubourg Stephanie Schaum-hautschutzcreme
US6075056A (en) * 1997-10-03 2000-06-13 Penederm, Inc. Antifungal/steroid topical compositions
AUPP583198A0 (en) * 1998-09-11 1998-10-01 Soltec Research Pty Ltd Mousse composition
US20070269379A1 (en) * 2003-07-23 2007-11-22 Samir Mitragotri Penetration Enhancer Combinations for Transdermal Delivery
FR2871696B1 (fr) * 2004-06-17 2006-11-10 Galderma Sa Composition topique pour le traitement du psoriasis

Also Published As

Publication number Publication date
AUPP583198A0 (en) 1998-10-01
JP4603164B2 (ja) 2010-12-22
US20040184992A1 (en) 2004-09-23
EP1112062A1 (en) 2001-07-04
EP1872776A3 (en) 2008-07-23
ES2299258T3 (es) 2008-05-16
DE69937802T2 (de) 2008-12-04
WO2000015193A1 (en) 2000-03-23
ATE381315T1 (de) 2008-01-15
PT1112062E (pt) 2008-03-24
EP1872776B1 (en) 2013-07-24
DE69937802D1 (de) 2008-01-31
DK1112062T3 (da) 2008-04-28
EP1112062A4 (en) 2005-06-08
AU760153B2 (en) 2003-05-08
NZ508259A (en) 2003-11-28
US7029659B2 (en) 2006-04-18
EP1872776A2 (en) 2008-01-02
US6730288B1 (en) 2004-05-04
EP1112062B1 (en) 2007-12-19
CA2333869A1 (en) 2000-03-23
JP2002524490A (ja) 2002-08-06
CA2333869C (en) 2009-01-06
US20060104912A1 (en) 2006-05-18
AU6069299A (en) 2000-04-03
ES2431330T3 (es) 2013-11-26

Similar Documents

Publication Publication Date Title
BR9913154A (pt) Composição de musse
ES2155931T3 (es) Forma de administracion de un agente activo de liberacion prolongada en banda.
WO2002005789A3 (de) Lösung, dispersion oder emulsion bildende folien-dermatika
BR0107869A (pt) Composições farmacêuticas eletrogiradas
DK1299108T3 (da) Parasiticidt præparat samt fremgangsmåde til fremstilling af dette præparat
BRPI0412975A (pt) espuma penetrante para uso farmacêutico
AR021922A1 (es) Formulaciones farmaceuticas en aerosol que contienen fluoroalcanos, budesonido y formoterol.
ATE345757T1 (de) Verabreichung eines arzneistoffs mittels einer sich-phasenumwandelnden formulierung
NO20001567D0 (no) Bioadhesive sammensetninger og fremgangsmåter for topisk administrering av aktive midler
BR0109150A (pt) Método para administração de um anestésico local a um indivìduo em necessidade de um efeito anestésico local, emplastro, composição, e, recipiente
DE60129849D1 (de) Bioadhäsiver schaumstoffilm mit hinhaltender wirkstoffreigabe
MXPA01003182A (es) Sistema de liberacion controlada de agentes antifungicos y queratoliticos para el tratamiento local de las infecciones fungicas de la una y los tejidos circundantes.
AR025071A1 (es) Aditivo para mejorar la resistencia al agua de formulaciones cosmeticas o dermatologicas
ES2175799T3 (es) Forma de dosificacion para administracion en aerosol.
MX174127B (es) Formulaciones medicinales en aerosol
ES2113444T3 (es) Medicamentos.
PT98105A (pt) Processo para a preparacao de formulacoes em aerossol contendo como propulsor 1,1,1,2-tetrafluoroetano
CO4940392A1 (es) Composicion para dejar en la piel de limpieza antimicrobiana que comprende un activo antimicrobiano, un surfactante, agen tes y agua
BR9907666A (pt) Preparações tópicas anìdricas para a pele
AR032352A1 (es) Composicion farmaceutica bioadhesiva de hidratacion gradual y su uso en la fabricacion de un medicamento para la administracion de testosterona y terbutalina a un mamifero a traves de una superficie de mucosa.
AR018109A1 (es) FORMULACIoN GALÉNICA ADMINISTRABLE POR VíA ORAL QUE PERMITE UNA ABSORCIoN MEJORADA DE PRINCIPIOS ACTIVOS, USO DE UN AGENTE MAJORADOR DE ABSORCIoN PARA PREPARAR UNA FORMA DE DOSIFICACIoN ADMINISTRABLE POR VíA ORAL Y PROCEDIMIENTO PARA PREPARAR DICHA FORMULACIoN GALÉNICA
BR0114909A (pt) Dispositivos de distribuição de drogas transdérmicas possuindo microprotuberâncias revestidas
BR9805993A (pt) Composição farmacêutica de aerosol.
MXPA01006926A (es) Formulaciones para tratar enfermedades y metodos para usar las mismas.
MX9205384A (es) Dispositivo de administracion transdermica de un agente activo para uso veterinario.

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B25D Requested change of name of applicant approved

Owner name: STIEFEL RESEARCH AUSTRALIA PTY LTD. (AU)

Free format text: ALTERADO DE: CONNETICS AUSTRALIA PTY LTD.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIDO O PEDIDO COM BASE NOS ARTIGOS 8O, 11 E 13 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]